Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
24.4M
-
Shares change
-
+1.61M
-
Total reported value, excl. options
-
$198M
-
Value change
-
+$13.3M
-
Number of buys
-
48
-
Number of sells
-
-34
-
Price
-
$8.12
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q2 2025
103 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q2 2025.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.4M shares
of 37.4M outstanding shares and own 65.14% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (4.7M shares), Legion Partners Asset Management, LLC (4.43M shares), Greenhaven Road Investment Management, L.P. (3.69M shares), 325 CAPITAL LLC (2.16M shares), BlackRock, Inc. (1.87M shares), VANGUARD GROUP INC (1.61M shares), GEODE CAPITAL MANAGEMENT, LLC (775K shares), MORGAN STANLEY (740K shares), GRIZZLYROCK CAPITAL, LLC (735K shares), and STATE STREET CORP (531K shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.